Article Name Global/International

Geneoscopy Secures FDA Approval for New At-Home Stool Collection Method

Simplified Process Aims to Boost Participation in Colorectal Cancer Screening and Improve Early Detection Rates

25th July, 2025


Hyperfine Showcases Swoop® AI-Powered Portable MRI in Dementia Care Studies

Clinical research highlights the potential of Hyperfine’s portable brain imaging system to improve early diagnosis and expand access to neuroimaging in underserved dementia populations.

25th July, 2025


Dispatch Bio Launches to Advance Universal Immunotherapy Platform for Solid Tumors

Biotech startup aims to transform cancer treatment with novel immune-based technology targeting a broad spectrum of solid tumor types

24th July, 2025


Roche Secures CE Mark for Alzheimer’s Blood Test

New minimally invasive diagnostic aids in ruling out Alzheimer’s disease early, expanding access to timely and accurate neurological assessments across Europe.

24th July, 2025


Philips Secures FDA Clearance for Image-Guided Navigation Technology in Prostate Cancer Care

Breakthrough Minimally Invasive Solution Enhances Precision in Targeted Therapy Procedures, Supporting Improved Outcomes in Prostate Cancer Treatment

24th July, 2025


Natus Integrates Moberg CNS Monitor with NeuroWorks for Advanced EEG Capabilities

The integration enhances multimodal brain monitoring by streamlining EEG data access, visualization, and clinical decision-making in critical care environments.

23rd July, 2025


The FDA Is Phasing Out Animal Testing

As regulatory shifts accelerate, next-generation non-animal models must rapidly evolve to ensure safety, efficacy, and innovation in human drug development.

23rd July, 2025


Hesperos Unveils First Digital Twin of Human Disease with Organ-on-a-Chip Breakthrough

Landmark integration of in vitro organ-on-a-chip and computational modeling marks a pivotal advancement in disease simulation, drug testing, and personalized medicine.

23rd July, 2025


Canada Grants Patent to bioAffinity Technologies for CyPath® Lung Diagnostic Test

New patent strengthens global IP portfolio for noninvasive lung cancer detection platform, expanding bioAffinity’s reach into international markets

23rd July, 2025


SkylineDx's Merlin Melanoma Assay Validated to Reduce Sentinel Lymph Node Biopsies by Over 40%

Danish multicenter study confirms clinical utility of genomic test in identifying low-risk stage I–II melanoma patients, advancing precision in surgical decision-making

22nd July, 2025


Takeda Secures FDA 510(k) Clearance for HyHub™ and HyHub™ Duo Devices

New devices designed to streamline and personalize HYQVIA® administration for patients receiving subcutaneous immune globulin therapy

22nd July, 2025


Spirair Secures FDA Clearance for TurbAlign™ Bioabsorbable Nasal Implant

Innovative device designed to maintain sinus patency post-surgery, enhancing healing and patient comfort without the need for removal

22nd July, 2025


Johnson & Johnson Unveils Global Insights on the Future of Surgical Software

New global report explores the transformative role of digital platforms, AI, and connectivity in reshaping surgical precision, training, and patient outcomes across healthcare systems.

21st July, 2025


Johnson & Johnson’s TAR-200 for Bladder Cancer Granted FDA Priority Review

NDA for TAR-200 targets high-risk non-muscle invasive bladder cancer, highlighting potential to transform treatment for patients unresponsive to BCG therapy

21st July, 2025


Onco-Innovations Appoints Dr. Dennis Hall to Scientific & Clinical Advisory Board

Renowned oncology expert joins to support advancement of next-generation cancer diagnostics and therapeutics.

21st July, 2025


ZEISS CLARUS 700 Gains Regulatory Nod in China, Expanding Ophthalmic Portfolio

The NMPA approval of the ZEISS CLARUS 700 represents a major leap forward in ultra-widefield retinal imaging, offering high-resolution, true color visualization to support early detection and management of complex eye diseases across China.

21st July, 2025


Globus Medical Launches DuraPro™ with Navigation

Next-Generation Oscillating System Enhances Precision and Protects Delicate Tissue in Spine and Cranial Procedures

18th July, 2025


HemoSonics Honored with 2025 Supplier Horizon Award by Premier, Inc.

Award Recognizes HemoSonics’ Innovative Contributions and Exceptional Support in Advancing Diagnostic Hemostasis Solutions Across Premier’s Member Network

18th July, 2025


Medtech Special

© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer